COVID Vaccine

7 May 2021 News release (WHO) WHO today listed the Sinopharm COVID-19 vaccine for emergency use, giving the green light for this vaccine to be rolled out globally. The Sinopharm vaccine is…

Some signs of recovery emerging but major efforts required to restore and strengthen health services The second round of a World Health Organization “pulse survey“ reveals that over one year into…

HIGHLIGHTS The COVAX Facility has notified participating economies that deliveries of doses from the Serum Institute of India (SII) will be delayed in March and April. Delays in securing supplies…

Assessments by World Bank and partners provide insights into more than 120 countries’ readiness to safely distribute vaccines WASHINGTON, March 18, 2021 – As countries undertake the largest vaccination campaign in…

As of 17 March 2021, more than 120 million cases of COVID-19 infections, with more than 2 million deaths, had been reported globally.  Vaccination remains a critical tool to help…

12 March 2021 News release Geneva The World Health Organization (WHO) listed the COVID-19 vaccine Ad26.COV2.S, developed by Janssen (Johnson & Johnson), for emergency use in all countries and for COVAX roll-out. The…

The World Health Organization (WHO) and Chubb Limited (NYSE: CB), through ESIS Inc., a Chubb company, signed an agreement on behalf of the COVAX Facility on 17 February 2021 for…

Declaration We must accelerate vaccine equity for all health workers – now Health and care workers have been at the forefront of the pandemic response: often under protected and over…

AstraZeneca/Oxford-developed vaccines to reach countries in the coming weeks 15 February 2021 The World Health Organization (WHO) listed two versions of the AstraZeneca/Oxford COVID-19 vaccine for emergency use, giving the…

The Ministry of Health & Population has released Frequently Asked Questions (FAQs) on the COVID-19 vaccine. The COVID-19 vaccination campaign will be launched from Jan 27, 2021 in Nepal.